Risk factors for progressive multifocal leukoencephalopathy identified in natalizumab-treated patients

被引：0
|
作者：
机构：
来源：
Nature Reviews Neurology | 2012年 / 8卷 / 7期
关键词：
D O I：
10.1038/nrneurol.2012.122
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：358 / 358
相关论文
共 50 条
  • [21] Reversible leukoencephalopathy syndrome mimicking progressive multifocal leukoencephalopathy in a long-term natalizumab-treated multiple sclerosis patient
    Haghikia, A.
    Decard, B.
    Toennes, C.
    Lukas, C.
    Chan, A.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S225 - S225
  • [22] Subacute Amotivational Syndrome as the Only Symptom of Progressive Multifocal Leukoencephalopathy in a Natalizumab-Treated Multiple Sclerosis Patient
    Babinski, Kristen
    Howard, Jonathan
    Gottschalk, Christopher
    Herbert, Joseph
    Kister, Ilya
    NEUROLOGY, 2011, 76 (09) : A637 - A637
  • [23] Facilitation of Progressive Multifocal Leukoencephalopathy Progression in Natalizumab-Treated Multiple Sclerosis Patients by Suppression of Viral Clearance wth Corticosteroids
    Ko, Michael
    Balabanov, Roumen
    Stefoski, Dusan
    NEUROLOGY, 2013, 80
  • [24] Progressive multifocal leukoencephalopathy and natalizumab
    Hellwig, Kerstin
    Gold, Ralf
    JOURNAL OF NEUROLOGY, 2011, 258 (11) : 1920 - 1928
  • [25] Natalizumab and Progressive Multifocal Leukoencephalopathy
    Warnke, Clemens
    Menge, Til
    Hartung, Hans-Peter
    Racke, Michael K.
    Cravens, Petra D.
    Bennett, Jeffrey L.
    Frohman, Elliot M.
    Greenberg, Benjamin M.
    Zamvil, Scott S.
    Gold, Ralf
    Hemmer, Bernhard
    Kieseier, Bernd C.
    Stuve, Olaf
    ARCHIVES OF NEUROLOGY, 2010, 67 (08) : 923 - 930
  • [26] Natalizumab and progressive multifocal leukoencephalopathy
    Adelman, B
    Sandrock, A
    Panzara, MA
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (04): : 432 - 433
  • [27] Progressive multifocal leukoencephalopathy and natalizumab
    Kerstin Hellwig
    Ralf Gold
    Journal of Neurology, 2011, 258 : 1920 - 1928
  • [28] CONTRIBUTION OF NATALIZUMAB EXPOSURE, PRIOR IMMUNOSUPPRESSANT (IS) USE, AND JC VIRUS (JCV) INFECTION TO PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) RISK IN NATALIZUMAB-TREATED MULTIPLE SCLEROSIS (MS) PATIENTS
    Bloomgren, G.
    Richman, S.
    Goelz, S.
    Hotermans, C.
    Hyde, R.
    Natarajan, A.
    Lee, S.
    Plavina, T.
    Subramanyam, M.
    Sandrock, A. W.
    Bozic, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 60 - 60
  • [29] Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
    Bloomgren, Gary
    Richman, Sandra
    Hotermans, Christophe
    Subramanyam, Meena
    Goelz, Susan
    Natarajan, Amy
    Lee, Sophia
    Plavina, Tatiana
    Scanlon, James V.
    Sandrock, Alfred
    Bozic, Carmen
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (20): : 1870 - 1880
  • [30] Risk stratification of progressive multifocal leukoencephalopathy under natalizumab
    Warnke, C.
    Adams, O.
    Hartung, H. P.
    Gold, R.
    Hemmer, B.
    Hohlfeld, R.
    Stangel, M.
    Zipp, F.
    Wiendl, H.
    Kieseier, B. C.
    NERVENARZT, 2011, 82 (10): : 1314 - 1319
12345